Innovating Works

ABBVIE INC

Desconocido
OPTIMA: Optimal treatment for patients with solid tumours in Europe through Artificial intelligence ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage OPTIMA is a multi-stakeholder-led consortium with the vision that each and every patient should have access to the most up-to-date individua...
2021-10-18 - 2026-09-30 | Financiado
RealHOPE: Real World Handling of Protein Drugs Exploration Evaluation and Education ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients...
2021-07-05 - 2025-06-30 | Financiado
HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY PLUS ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2019-19-single-stage Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be e...
2020-05-26 - 2024-03-31 | Financiado
Trials@Home: Trials@Home Center of Excellence Remote Decentralised Clinical Trials ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage Clinical trials increase in size, complexity and costs. This is fuelled with the need to demonstrate effects in more complex therapeutic are...
2019-08-07 - 2025-11-30 | Financiado
EHDEN: European Health Data and Evidence Network ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage Europe is generating huge amounts of patient-level information contained in Electronic Health Record (EHR) systems and other types of health...
2018-11-22 - 2024-10-31 | Financiado
WEB-RADR 2: WEB RADR 2 ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2017-11-single-stage This proposal seeks to build on the mobile application (app) functionality delivered through the original WEB-RADR project to expand access...
2018-09-10 - 2020-06-30 | Financiado
EFOEUPATI: Ensuring the future of EUPATI beyond 2020 ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2017-11-single-stage The European Patients' Academy on Therapeutic Innovation (EUPATI) IMI project resulted in a number of key outputs for the field of patient e...
2018-06-21 - 2020-09-30 | Financiado
eTRANSAFE: Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Drug safety assessment is a knowledge-intensive process that demands advancement in data handling methods and tools for facilitating data sh...
2017-09-12 - 2023-02-28 | Financiado
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY Sofia ref.... ABBVIE INC participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in qual...
2016-12-22 - 2023-06-30 | Financiado
PREDECT: New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours ABBVIE INC participó en un FP7: Traditional preclinical discovery methods, particularly for target validation, poorly predict drug efficacy, causing a high attrition rate i...
Financiado
APPROACH: Applied Public Private Research enabling OsteoArthritis Clinical Headway ABBVIE INC participó en un FP7: The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharm...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.